Depression in epilepsy: Ignoring clinical expression of neuronal network dysfunction?

Epilepsia

Volumn 45, Issue SUPPL. 2, 2004, Pages 28-33

  Gilliam, Frank G ^a,b   Santos, Juan ^a   Vahle, Victoria ^a   Carter, Jewell ^a   Brown, Kelly ^a   Hecimovic, Hrvoje ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Depression; Epilepsy; Functional imaging; PET; Quality of life; Seizures

Indexed keywords

SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

BRAIN DYSFUNCTION; CAUSE OF DEATH; CONFERENCE PAPER; DEPRESSION; DRUG EFFICACY; EPILEPSY; HEALTH STATUS; HUMAN; NERVE CELL NETWORK; PREFRONTAL CORTEX; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL DISABILITY; SOCIAL STATUS; SUICIDE; TEMPORAL LOBE;

EID: 3042763184     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0013-9580.2004.452005.x     Document Type: Conference Paper

References (43)

1. Hermann BP, Seidenberg M, Bell B. Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression. Epilepsia 2000;41(suppl 2):S31-41.
2. Gilliam F, Kanner AM. Treatment of depressive disorders in epilepsy patients. Epilepsy Behav 2002;358:S2-9.
3. Boylan LS, Flint LA, Labovitz DL, Jackson SC, Starner K, Devinsky O. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 2004;62:258-61.
4. Mendez MF, Cummings JL, Benson DF. Depression in epilepsy. Significance and phenomenology. Arch Neurol 1986;43:766-70.
5. Jacoby A, Baker GA, Steen N, Potts P, Chadwick DW. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. community study. Epilepsia 1996;37:148-61.
6. O'Donoghue MF, Goodridge DM, Redhead K, Sander JW, Duncan JS. Assessing the psychosocial consequences of epilepsy: a community-based study. Br J Gen Pract 1999;49:211-4.
7. Edeh J, Toone B. Relationship between interictal psychopathology and the type of epilepsy. Results of a survey in general practice. Br J Psychiatry 1987;151:95-101.
8. Robertson MM. Suicide, parasuicide, and epilepsy. In: Engel J, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia, PA: Lippincott-Raven; 1997.
9. Rafnsson V, Olafsson E, Hauser WA, Gudmundsson G. Cause-specific mortality in adults with unprovoked seizures. A population-based incidence cohort study. Neuroepidemiology 2001;20:232-6.
10. Nilsson L, Tomson T, Farahmand BY, Diwan V, Persson PG. Cause-specific mortality in epilepsy: a cohort study of more than 9,000 patients once hospitalized for epilepsy. Epilepsia 1997;38:1062-8.
11. Hermann BP, Trenerry MR, Colligan RC. Learned helplessness, attributional style, and depression in epilepsy. Bozeman Epilepsy Surgery Consortium. Epilepsia 1996;37:680-6.
12. Engel J, Jr., Caldecott-Hazard S, Bandler R. Neurobiology of behavior: anatomic and physiological implications related to epilepsy. Epilepsia 1986;27(suppl 2):S3-13.
13. Bromfield EB, Altshuler L, Leiderman DB, et al. Cerebral metabolism and depression in patients with complex partial seizures (published erratum appears in Arch Neurol 1992 Sep;49:976). Arch Neurol 1992;49:617-23.
14. Bromfield EB, Altshuler L, Leiderman DB, et al. Cerebral metabolism and depression in patients with complex partial seizures (published erratum appears in Arch Neurol 1992 Sep;49:976). Arch Neurol 1992;49:617-23.
15. Drevets WC, Price JL, Simpson JR, Jr., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997;386:824-7.
16. Victoroff JI, Benson F, Grafton ST, Engel J, Jr., Mazziotta JC. Depression in complex partial seizures. Electroencephalography and cerebral metabolic correlates. Arch Neurol 1994;51:155-63.
17. Quiske A, Helmstaedter C, Lux S, Elger CE. Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis. Epilepsy Res 2000;39:121-5.
18. Schmitz EB, Robertson MM, Trimble MR. Depression and schizophrenia in epilepsy: social and biological risk factors. Epilepsy Res 1999;35:59-68.
19. Gilliam FG, Fessler AJ, Baker G, Vahle V, Carter J, Attarian H. Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 2004;62:23-7.
20. Lambert MV, Robertson MM. Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia 1999;40(suppl 10):S21-47.
21. Kanner AM, Nieto JC. Depressive disorders in epilepsy. Neurology 1999;53(5 suppl 2):S26-32.
22. Ojemann LM, Baugh-Bookman C, Dudley DL. Effect of psychotropic medications on seizure control in patients with epilepsy. Neurology 1987;37:1525-7.
23. Wiegartz P, Seidenberg M, Woodard A, Gidal B, Hermann B. Comorbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression. Neurology 1999;53(5 suppl 2):S3-8.
24. Whalley D, McKenna SP. Measuring quality of life in patients with depression or anxiety. Pharmacoeconomics 1995;8:305-15.
25. Gilliam F, Hecimovic H, Sheline Y, et al. Psychiatric comorbidity, health, and function in epilepsy. Epilepsy Behav 2003;4(suppl 4):S26-30.
26. Settle EC, Jr. Antidepressant drugs: disturbing and potentially dangerous adverse effects. J Clin Psychiatry 1998;59(suppl 16):25-30; discussion 25-30.
27. Pisani F, Spina E, Oteri G. Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice. Epilepsia 1999;40(suppl 10):S48-56.
28. Gilliam F. Optimizing health outcomes in active epilepsy. Neurology 2002;58(suppl 5):S9-19.
29. Brooke G, Weatherly JRC. Imipramine. Lancet 1959;2:568-9.
30. Robertson MM, Trimble MR. The treatment of depression in patients with epilepsy. A double-blind trial. J Affect Disord 1985;9:127-36.
31. Kanner AM, Kozak AM, Frey M. The use of sertraline in patients with epilepsy: Is it safe? Epilepsy Behav 2000;1:100-5.
32. Blumer D. Antidepressant and double antidepressant treatment for the affective disorder of epilepsy. J Clin Psychiatry 1997;58:3-11.
33. Leppik IE. How to get patients with epilepsy to take their medication. The problem of noncompliance. Postgrad Med 1990;88:253-6.
34. Helgeson DC, Mittan R, Tan SY, Chayasirisobhon S. Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in treating medical and psychosocial aspects of epilepsy. Epilepsia 1990;31:75-82.
35. Ayres A, Hoon PW, Franzoni JB, Matheny KB, Cotanch PH, Takayanagi S. Influence of mood and adjustment to cancer on compliance with chemotherapy among breast cancer patients. J Psychosom Res 1994;38:393-402.
36. Bosley CM, Fosbury JA, Cochrane GM. The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J 1995;8:899-904.
37. Edinger JD, Carwile S, Miller P, Hope V, Mayti C. Psychological status, syndromatic measures, and compliance with nasal CPAP therapy for sleep apnea. Percept Mot Skills 1994;78(3 Pt 2):1116-8.
38. Frazier PA, Davis-Ali SH, Dahl KE. Correlates of noncompliance among renal transplant recipients. Clin Transplant 1994;8:550-7.
39. McDonough EM, Boyd JH, Varvares MA, Maves MD. Relationship between psychological status and compliance in a sample of patients treated for cancer of the head and neck. Head Neck 1996;18:269-76.
40. Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care 1996;8:261-9.
41. Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann KA, Rudick RA. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol 1997;54:53-3.
42. Souetre E, Martin P, Lozet H, Monteban H. Quality of life in depressed patients: comparison of fluoxetine and major tricyclic antidepressants. Int Clin Psychopharmacol 1996;11:45-52.
43. Gilliam F, Kuzniecky R, Meador K, et al. Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy [Comments]. Neurology 1999;53:687-94.